Kaiwal Patel1, Sukhman Shergill1, Nalini Vadivelu1, Kanishka Rajput2. 1. Department of Anesthesiology and Pain Medicine, Yale University School of Medicine, 333 Cedar St, TMP3, New Haven, CT 06510, Connecticut, US. 2. Department of Anesthesiology and Pain Medicine, Yale University School of Medicine, 333 Cedar St, TMP3, New Haven, CT 06510, Connecticut, US. kanishka.rajput@yale.edu.
Abstract
PURPOSE OF REVIEW: Gynecologic oncologic malignancies are amongst the most common cancers affecting women across the world. This narrative review focuses on the current state of evidence around optimal perioperative pain management of patients undergoing surgeries for gynecologic malignancies with a specific focus on cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). RECENT FINDINGS: Recent improvements in postoperative pain management following all types of gynecologic procedures, including minimally invasive, open-abdominal, or CRS + HIPEC, have been implemented through enhanced recovery after surgery (ERAS) protocols. These protocols encompass the use of preemptive analgesia, neuraxial and regional techniques, local anesthetic infiltration, and multimodal analgesia. The severity of postoperative pain varies for minimally invasive cancer surgery to open debulking procedures. Therefore, an individualized perioperative analgesic plan is critical depending on the surgical approach. For CRS + HIPEC, neuraxial techniques such as thoracic epidurals and opioid sparing multimodal analgesics have shown efficacy in the perioperative period. However, future research is needed as many of these patients develop chronic pain with very limited research done in this realm.
PURPOSE OF REVIEW: Gynecologic oncologic malignancies are amongst the most common cancers affecting women across the world. This narrative review focuses on the current state of evidence around optimal perioperative pain management of patients undergoing surgeries for gynecologic malignancies with a specific focus on cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). RECENT FINDINGS: Recent improvements in postoperative pain management following all types of gynecologic procedures, including minimally invasive, open-abdominal, or CRS + HIPEC, have been implemented through enhanced recovery after surgery (ERAS) protocols. These protocols encompass the use of preemptive analgesia, neuraxial and regional techniques, local anesthetic infiltration, and multimodal analgesia. The severity of postoperative pain varies for minimally invasive cancer surgery to open debulking procedures. Therefore, an individualized perioperative analgesic plan is critical depending on the surgical approach. For CRS + HIPEC, neuraxial techniques such as thoracic epidurals and opioid sparing multimodal analgesics have shown efficacy in the perioperative period. However, future research is needed as many of these patients develop chronic pain with very limited research done in this realm.
Authors: H O Topçu; S Cavkaytar; K Kokanalı; A I Guzel; M Islimye; M Doganay Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-09-16 Impact factor: 2.435
Authors: Alanna Lehman; Erin V Kemp; Jubilee Brown; Erin K Crane; David L Tait; Valerie D Taylor; R Wendel Naumann Journal: J Minim Invasive Gynecol Date: 2020-07-27 Impact factor: 4.137
Authors: Henning Hermanns; Elke M E Bos; Mark L van Zuylen; Markus W Hollmann; Markus F Stevens Journal: CNS Drugs Date: 2022-07-15 Impact factor: 6.497